Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
150.2 USD | +0.75% | +3.88% | -4.27% |
Apr. 22 | J&J: EU green light for Carvykti in multiple myeloma | CF |
Apr. 22 | Daiwa Securities Adjusts Johnson & Johnson's Price Target to $160 From $170, Maintains Outperform Rating | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- JNJ Stock
- Revisions Johnson & Johnson